| 标题 |
1066P Final results from the ENGOT-Ov41/GEICO 69-O/ANITA randomised phase III trial of atezolizumab (atezo), platinum-based chemotherapy (CT) and maintenance niraparib (nira) for late-relapsing recurrent ovarian cancer (rOC) |
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)